Occluders, Vascular, Intravascular Embolization

Definition : Vascular occluders designed for intravascular embolization, promoting complete vascular occlusion and thrombosis. These occluders typically consist of a small device (e.g., detachable balloon, metallic coil) or substance (e.g., gelatin-, alcohol-, or glue-based) that is deployed using guide wires and appropriate catheters. Intravascular embolization occluders are used for permanent occlusion of venous malformations and lesions in spinal and cerebral vessels (e.g., aneurysms); they are also used for abdominal (e.g., inferior vena cava) and peripheral vascular lesions. These devices are also used for occlusion of aortopulmonary collaterals, pulmonary arteriovenous fistulas, and some small (typically less than 4 mm) patent ductus arteriosus.

Entry Terms : "Embolization Prostheses, Intravascular" , "PDA Occluders" , "Occluders, Patent Ductus Arteriosus" , "Prostheses, Embolization" , "Intravascular Embolization Devices" , "Embolization Prostheses, Arterial" , "Embolization Glue, Intravascular"

UMDC code : 15034

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Boston Scientific Corp

Company Type: Parent

In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together.

Endologix Inc

Company Type: Parent

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA.

Sequent Medical Inc

Company Type: Parent

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone